European Medicines Agency
PulseAugur coverage of European Medicines Agency — every cluster mentioning European Medicines Agency across labs, papers, and developer communities, ranked by signal.
- 2026-05-21 product_launch Ema's co-founder discusses the company's AI agents being adopted by enterprise clients. source
3 day(s) with sentiment data
-
Clinical trial data reliability questioned despite FDAAA legislation
The reliability of clinical trial data is undermined by methodological flaws, despite existing legislation like the FDAAA. Independent, peer-reviewed data, beyond mere press releases, are crucial for accurately assessin…
-
AI agents to automate pharmaceutical manufacturing, shifting human roles to oversight
Nagesh Nama, CEO of xLM, proposes the concept of a "self-driving pharmaceutical company" that leverages AI agents and a company-wide context graph to automate manufacturing processes. This model aims to reduce the time …
-
New LLM Benchmark Detects Regulatory Contradictions Between US and EU
Researchers have developed RegDivergence-101, a new benchmark designed to evaluate Large Language Models (LLMs) in detecting contradictions and silences between regulatory documents from different jurisdictions, specifi…
-
MLLMs Enhance Text-to-Video Generation with Semantic Correction and Visual Planning
Two new research papers explore enhancing text-to-video generation by integrating multimodal large language models (MLLMs) with diffusion models. The first paper introduces a framework that injects MLLM feedback directl…
-
Gemini fine-tuning experiment targets EMA medical data
An AI engineer experimented with fine-tuning Google's Gemini model to process complex medical information, specifically the European Medicines Agency's SmPC posology data. The goal was to see if a smaller, fine-tuned mo…
-
Congress targets insulin costs and drug patent abuses
Congress is advancing legislation aimed at reducing prescription drug costs and reforming patent practices. The INSULIN Act, which has passed a key Senate committee, proposes capping out-of-pocket insulin costs at $35 p…
-
AI automates patient outcome data processing for regulatory submissions
Artificial intelligence, particularly natural language processing and large language models, is revolutionizing the collection and analysis of patient-reported outcomes (PROs) in clinical research. These AI tools automa…
-
AI virtual organ simulation platform CANCHEN TECH raises tens of millions RMB
CANCHEN TECH (璨辰科技) has secured tens of millions of RMB in a series of seed and angel funding rounds from investors including Oriental Fortune Capital and Songhe Capital. The company specializes in developing AI-powered…
-
New STST-JEPA model advances EEG self-supervised learning for brain-age prediction
Researchers have developed STST-JEPA, a novel self-supervised transformer architecture designed for electroencephalography (EEG) data. This model, pretrained on a large dataset of over 47,000 EEG sessions, aims to impro…
-
Pharma maintenance shifts to AI-driven predictive systems to ensure compliance
Modern pharmaceutical manufacturing requires a sophisticated computerized maintenance management system (CMMS) to handle the critical nature of equipment failures. Unlike other industries, equipment downtime in pharma c…
-
Reddit user seeks EMA on LoRA adapter applications
A user on the r/MachineLearning subreddit is seeking information about the successful application of Exponential Moving Average (EMA) techniques specifically with LoRA (Low-Rank Adaptation) adapters. They are interested…
-
AI agent monitors flawed by wall-clock calibration, study finds
A new research paper, "Bistable by Construction: Wall-Clock-Calibrated State Monitors Have No Moment-Detection Regime at Agent Cadence," published on arXiv, identifies a critical flaw in runtime monitors for autonomous …
-
Ningbo Yun Sheng seeks HK listing; Innovent licenses DMX-200
Ningbo Yun Sheng has submitted an application to the Hong Kong Stock Exchange for an H-share issuance and listing. Separately, Innovent Biologics has entered into an exclusive licensing agreement with Dimerix Limited to…
-
FDA Outpaces Pharma with Real-Time AI Clinical Trials
The FDA has successfully implemented a real-time clinical trial data system, allowing for immediate review of patient safety signals. This transformation was driven by the rapid, agency-wide adoption of an AI assistant …
-
AI agents are replacing traditional software in enterprise
AI agents are increasingly being adopted by Fortune 500 companies for tasks in HR, IT, finance, and customer service, according to Ema co-founder Swati Trehan. Traditional automation methods have proven insufficient, le…
-
Open-source tool grants AI full access to pharma R&D data
An open-source project called drug-pipeline-mcp has been released, offering AI agents comprehensive access to pharmaceutical R&D data. This tool aggregates information on clinical trials, FDA/EMA approvals, safety repor…
-
AI models achieve high accuracy in brain tumor classification and segmentation
Researchers have developed two distinct deep learning frameworks for brain tumor analysis using MRI scans. One framework utilizes a Vision Transformer (ViT-B/16) for automated four-class tumor classification, achieving …